The fifteen percent issue in molecular-based diagnosis of follicular thyroid carcinoma

Pathology International

Volumn 61, Issue 3, 2011, Pages 165-166

  Takano, Toru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TFF3 PROTEIN; UNCLASSIFIED DRUG;

CANCER DIAGNOSIS; CANCER INVASION; DISTANT METASTASIS; DNA MICROARRAY; GENE EXPRESSION; GENE TARGETING; HUMAN; LETTER; MARKER GENE; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; SERIAL ANALYSIS OF GENE EXPRESSION; THYROID FOLLICULAR CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; DNA, NEOPLASM; GENE EXPRESSION PROFILING; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM INVASIVENESS; PEPTIDES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952076750     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02622.x     Document Type: Letter

References (14)

1. Bartolazzi A, Gasbarri A, Papotti M etal. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644-50.
2. Cerutti JM, Delcelo R, Amadei MJ etal. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 2004; 113: 1234-42.
3. Weber F, Shen L, Aldred MA etal. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 2005; 90: 2512-21.
4. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N. High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 2004; 90: 1600-5.
5. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 2005; 219: 91-6.
6. Foukakis T, Gusnanto A, Au AY etal. A PCR-based expression signature of malignancy in follicular thyroid tumors. Endocr Relat Cancer 2007; 14: 381-91.
7. Krause K, Eszlinger M, Gimm O etal. TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency. J Clin Endocrinol Metab 2008; 93: 1390-3.
8. Durand S, Ferraro-Peyret C, Selmi-Ruby S etal. Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. J Clin Endocrinol Metab 2008; 93: 1195-202.
9. Barden CB, Shister KW, Zhu B etal. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 2003; 9: 1792-800.
10. Ito Y, Yabuta T, Hirokawa M etal. Distant and lymph node metastases of thyroid nodules with no pathological evidence of malignancy: a limitation of pathological examination. Endocr J 2008; 55: 889-94.
11. Taniguchi K, Takano T, Miyauchi A etal. Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction. Oncology 2005; 69: 428-35.
12. Yamamoto Y, Maeda T, Izumi K, Otsuka H. Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases. Cancer 1990; 65: 1173-9.
13. Ito Y, Miyauchi A, Inoue H etal. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 2010; 34: 28-35.
14. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19: 545-76.